Crossref
Weekly HIV pill moves closer but vaccine studies face new questions
Science · 06.08.2026 · 393 (6811) · 549-550
DOI: 10.1126/science.ael2155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 06.08.2026. Verfasst von Jon Cohen. Beteiligte Einrichtung: Rio de Janeiro. Hauptthemen laut MEDLINE: AIDS Vaccines, HIV Antibodies, HIV Infections, HIV-1.
Abstract (Originalsprache)
Potent antibodies that researchers hope vaccines can elicit didn’t prevent HIV in a major trial
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AIDS VaccinesHIV AntibodiesHIV InfectionsHIV-1Pre-Exposure ProphylaxisAcetamidesIndazolesAnti-HIV AgentsDeoxyadenosinesHumansDrug Combinations
Substanzen
AIDS VaccinesHIV AntibodieslenacapavirislatravirAcetamidesIndazolesAnti-HIV AgentsDeoxyadenosinesDrug Combinations
Autor:innen und Institutionen
- Rio de Janeiro.
Zitieren
APA
Cohen, J. (2026). Weekly HIV pill moves closer but vaccine studies face new questions. Science, 393(6811), 549-550. https://doi.org/10.1126/science.ael2155
Vancouver
Cohen J. Weekly HIV pill moves closer but vaccine studies face new questions. Science. 2026;393(6811):549-550. doi:10.1126/science.ael2155
BibTeX
@article{Cohen2026,
author = {Cohen, Jon},
title = {Weekly HIV pill moves closer but vaccine studies face new questions},
journal = {Science},
year = {2026},
volume = {393},
number = {6811},
pages = {549--550},
doi = {10.1126/science.ael2155}
}
EUVIMED